|
|
Article: CSMG Technologies CEO Featured in Exclusive Interview with Wall Street Reporter; Live Tissue Connect Subsidiary, Focused On Commercialization Of Human Live Tissue Bonding Devices, Is Discussed In Detail.
- Article from:
- Business Wire
- Article date:
- August 28, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CORPUS CHRISTI, Texas -- CSMG Technologies, Inc. (OTCBB:CTUM), focused on commercializing human live tissue bonding devices, and renewable energy technologies, announced Donald S. Robbins, CEO of CSMG Technologies, updated the investment community, and shareholders, in an exclusive interview with Wall Street Reporter. The interview focused primarily on CSMG's Live Tissue Connect subsidiary, highlighting targeted markets, recent operating achievements, including the just announced progress in liver and spleen procedures, and other developments.
To hear the interview
To hear the interview in its entirety, visit ...
Related newspaper, magazine, and journal articles:
|
|
Article: CSMG Technologies and Live Tissue ...
Business Wire;
August 18, 2008 ;
700+ words
... ... Robbins, along with Live Tissue Connect, Inc ... presentation regarding CSMG Technologies, including its ... instruments. About CSMG Technologies, Inc. CSMG Technologies, Inc. (OTCBB ... technologies. Subsidiary Live Tissue Connect (LTC ...
|
|